However, the complexity of stem cell-dependent therapies often qualified prospects scientists to look for stable, Safe and sound and easily obtainable stem cells supply which has the likely to differentiate into several lineages.In January 2009, the US Meals and Drug Administration gave clearance to Geron Corporation for the primary clinical demo o